Detalhe da pesquisa
1.
Overcoming cancer-associated fibroblast-induced immunosuppression by anti-interleukin-6 receptor antibody.
Cancer Immunol Immunother
; 72(7): 2029-2044, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-36764954
2.
Nanog is a promising chemoresistant stemness marker and therapeutic target by iron chelators for esophageal cancer.
Int J Cancer
; 149(2): 347-357, 2021 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33662150
3.
A combined prediction model for biliary tract cancer using the prognostic nutritional index and pathological findings: a single-center retrospective study.
BMC Gastroenterol
; 21(1): 375, 2021 Oct 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-34645392
4.
Preoperative Albumin-to-Globulin Ratio Predicts Prognosis in Hepatocellular Carcinoma: A Cohort Study Including Non-Hepatitis Virus-Infected Patients.
Dig Surg
; 38(4): 307-315, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34515102
5.
[A case of metastatic carcinoma of the colon after curative resection for gastric cancer].
Gan To Kagaku Ryoho
; 40(12): 2182-4, 2013 Nov.
Artigo
em Japonês
| MEDLINE | ID: mdl-24394053
6.
Conventional Cancer Therapies Can Accelerate Malignant Potential of Cancer Cells by Activating Cancer-Associated Fibroblasts in Esophageal Cancer Models.
Cancers (Basel)
; 15(11)2023 May 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-37296933
7.
C-reactive protein to albumin ratio predicts difficult laparoscopic cholecystectomy in patients with acute cholecystitis diagnosed according to the Tokyo Guidelines 2018.
Asian J Endosc Surg
; 15(3): 487-494, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35137536
8.
Dual-targeted near-infrared photoimmunotherapy for esophageal cancer and cancer-associated fibroblasts in the tumor microenvironment.
Sci Rep
; 12(1): 20152, 2022 11 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-36418422
9.
Comparison of Inflammation-based Prognostic Scores in Patients With Biliary Tract Cancer After Surgical Resection.
Anticancer Res
; 41(4): 2147-2155, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33813426
10.
A Novel Combination Cancer Therapy with Iron Chelator Targeting Cancer Stem Cells via Suppressing Stemness.
Cancers (Basel)
; 11(2)2019 Feb 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30717462